ISTH 2022 Congress
Hemostatic Systems in Cancer, Inflammation and Immunity
Theme Navigation
- ISTH 2022 Congress
- Hemostatic Systems in Cancer, Inflammation and Immunity
-
Abstract Number: PB0726
(Factor VIII / Factor V) Ratio as a New Prognostic Marker for Decompensated Liver Cirrhosis
-
Abstract Number: PB0777
Adenovirus-based but not mRNA-based vaccines transiently alter platelet count homeostasis in healthy subjects.
-
Abstract Number: VPB0746
Alterations in Coagulation Profiles and Bleeding Rates in Patients with Acute Myeloid Leukemia/Myelodysplastic Syndrome on Prophylactic Anti-Bacterials
-
Abstract Number: PB0728
Bladder cancer patients have increased NETosis and impaired DNaseI-mediated NET degradation that can be therapeutically restored in vitro
-
Abstract Number: VPB0759
Cancer-associated fibroblasts promote venous thrombosis through C-type lectin-like receptor 2/podoplanin in 3LL lung cancer mouse model
-
Abstract Number: PB0743
Cell-free DNA is increased in plasma of immunothrombotically dysregulated patients with periprosthetic joint infection in part due to lower DNaseI activity
-
Abstract Number: PB0750
Changes to platelet quality and function in Waldenstrӧm Macroglobulinaemia
-
Abstract Number: PB0730
Circulating activated protein C levels are reduced in cancer patients, a novel contribution to tumorigenesis?
-
Abstract Number: OC 28.3
Coagulation factor XII induces persistent uPAR-integrin β1 signaling promoting DNA damage and senescence in diabetic kidneys
-
Abstract Number: OC 28.5
Coagulation FXI regulates endothelial cell barrier function by inducing VE-cadherin proteolysis in an ADAM10-dependent manner
-
Abstract Number: PB0744
Coagulation markers improve the diagnosis of periprosthetic joint infection: involvement of immunothrombosis
-
Abstract Number: PB0738
Complement and Haemostasis: Effects of complement inhibitors in a microfluidic bleeding model
-
Abstract Number: PB0729
Development of a viral vector for hemopexin protein expression for gene therapy in disorders associated with increased levels of free extracellular heme
-
Abstract Number: PB0748
Diminished platelet CLEC-2 sensitivity in kaposiform hemangioendothelioma identified with novel CLEC-2 antagonists
-
Abstract Number: OC 51.1
Direct oral anticoagulants cause placental vascular abnormalities and epigenetic reprogramming in placenta and the offspring
-
Abstract Number: PB0775
Disruption of the interaction of platelets with leukocytes by a novel short synthetic peptide targeting P-selectin
-
Abstract Number: PB0766
Essential oils and their sesquiterpenes reduce DENV-2-induced platelet activation
-
Abstract Number: OC 28.1
Factor X – Protease activated receptor-2 signaling in the regulation of diet-induced obesity
-
Abstract Number: PB0732
Fibrin Promotes Glioblastoma Progression via Focal Adhesion Kinase
-
Abstract Number: PB0733
Frequency of Factor II, Factor V Leiden and MTHFR mutations in children with cancer
- 1
- 2
- 3
- 4
- Next Page »